Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis

Figure 5 Validation of the 7 epithelial-mesenchymal transition-associated gene signature model in the validation cohort. A: The median value and distribution of the risk scores in the validation cohort; B: Principal component analysis (PCA) plot; C: Results of t-distributed stochastic neighbor embedding (t-SNE) analysis; D: The distributions of overall survival (OS) status for the high-risk group and the low-risk group; E: Kaplan-Meier analysis of OS for lung adenocarcinoma (LUAD) patients in the high-risk group and the low-risk group; F: The area under the curve (AUC) of the time-dependent receiver operator characteristic curve (ROC) validated the predictive performance of the prognostic risk score in the validation cohort.